Dr. Guido A. Perez

Medical Director and Co-Founder

Dr. Perez is a co-founder of BioMed Research Institute. He has over 25 years of experience as a physician. He worked in Havana, Cuba as an Internist for 10 years. Dr. Perez has worked as a Medical Doctor in Miami, FL since 1999. He has more than 15 years of experience as a Principal Investigator and Principal Investigator in several therapeutic areas. Dr. Perez took the 12th Annual Clinical Research training for physicians at University of North Florida, Jacksonville, FL.


Recent Studies


• A Phase 2, Multicenter, randomized, double blind study comparing the safety and efficacy of two doses of XXXX versus XXXX in patients with Acute Bacterial skin and skin structure infection.


• A Randomized, double blind, placebo controlled study of the efficacy and safety of insulin XXXX in the treatment of Type 11 Diabetic patients.


• A Placebo-Controlled, double blind Study of Inhaled Nitric Oxide (iNO) in subjects with Pulmonary Hypertension associated to Chronic Obstructive Pulmonary Disease (COPD) in long term Oxygen Therapy (L TOT).


• A Phase 2, Multicenter, Randomized, double-blind, placebo-controlled Study to evaluate the efficacy and safety of XXX XXX in subjects with Post Herpetic Neuralgia.


• A Phase 2, Randomized, Double-blind. Placebo-Controlled, Sequential Group, Multiple-Dose Escalation Study to Evaluate the Efficacy and Safety of XXX XXX in Subjects With Moderate to Severe Plaque Psoriasis.


• A Phase 3, Randomized, Double-blind Placebo-controlled Study of the Analgesic Efficacy of XXX XXX Compared to Placebo in Subjects With Chronic Low Back Pain.


• A Randomized Double-Blind Placebo Controlled Trial to Investigate the Efficacy and XXX XXX of Chronic Migraine.


• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study Assessing the Efficacy and Tolerability of XXX XXX for the Pain of Diabetic Peripheral Neuropathy.


• Efficacy and Safety of XXX XXX for the Treatment of Chronic Migraine: A Randomized, Double-Bl ind, Placebo-Controlled Trial.


Print Print | Sitemap
© BioMed Research Institute